Skip to main content
. 2022 Jan 24;8:797890. doi: 10.3389/fmed.2021.797890

Figure 6.

Figure 6

Forest plot depicting the SMD of Mexameter® reading reduction in patients with melasma receiving botanical products in RCTs. Subgroup analysis was stratified according to comparators.